R
Robert H. Bartlett
Researcher at University of Michigan
Publications - 569
Citations - 28295
Robert H. Bartlett is an academic researcher from University of Michigan. The author has contributed to research in topics: Extracorporeal membrane oxygenation & Extracorporeal. The author has an hindex of 81, co-authored 550 publications receiving 25619 citations. Previous affiliations of Robert H. Bartlett include University of California, Irvine & NewYork–Presbyterian Hospital.
Papers
More filters
Journal ArticleDOI
Successful Porcine Renal Transplantation After 60 Minutes of Donor Warm Ischemia: Extracorporeal Perfusion and Thrombolytics
David S. Demos,Amit Iyengar,Benjamin S. Bryner,Brian W. Gray,Hayley R. Hoffman,Marie S. Cornell,John E. Wilkinson,Daniel E. Mazur,Robert H. Bartlett,Jeffrey D. Punch,Alvaro Rojas-Pena +10 more
TL;DR: Thrombolytics plus ECS precondition organs in situ yielding functional kidneys in a porcine model of uDCD with 60 min of WIT is evaluated to address logistical limitations for uD CD use in the United States and could have a major impact on the organ donor pool.
Journal ArticleDOI
Development of an artificial placenta: CO2 elimination and hemodynamics as a function of arteriovenous blood flow.
Felicia A Ivascu,David Somand,Amy M. Skrzypchak,Sean D. Chambers,Robert H. Bartlett,Ronald B. Hirschl +5 more
TL;DR: In this rabbit model, A-V blood flows at 25% to 30% of cardiac output allow full gas exchange without hemodynamic compromise, which raises the possibility of using A-v support and an artificial placenta in newborns with respiratory failure.
Journal ArticleDOI
The effect of norepinephrine infusion on oxygen delivery and consumption in the canine model
Steven M. Boorstein,Ronald B. Hirschl,Michael K. Riley,Brian S. Kahan,Karl A. Hultquist,Robert H. Bartlett +5 more
TL;DR: The effectiveness of NE administration could be most effectively monitored by the mixed venous oxygen saturation (SVO2), rather than by intermittent assessment of BP, CO, or DO2.
Journal ArticleDOI
Preliminary In Vivo Testing of a Novel Pump for Short-Term Extracorporeal Life Support
David J. Spurlock,Kelly L. Koch,Daniel E. Mazur,Emilia M. Fracz,Robert H. Bartlett,Jonathan W. Haft +5 more
TL;DR: The BioVAD provided adequate flow in an acute in vivo model and may be superior for short-term extracorporeal support and afterload insensitive, and incapable of cavitation or excessive hemolysis.
Journal ArticleDOI
Comparison of Diazeniumdiolated Dialkylhexanediamines as Nitric Oxide Release Agents on Nonthrombogenicity in an Extracorporeal Circulation Model
TL;DR: Both DPHDN2O2 and DPHD n-N-di-N'-propyl-1,6-hexanediamine are good candidates as NO donor molecules for creating nonthrombogenic polymer coatings for ECCs and AG was no different than AG in preserving platelet count and function.